These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16361854)

  • 41. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carnitine replacement in end-stage renal disease and hemodialysis.
    Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
    Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. L-carnitine in dialysis patients.
    Ahmad S
    Semin Dial; 2001; 14(3):209-17. PubMed ID: 11422928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review.
    Hurot JM; Cucherat M; Haugh M; Fouque D
    J Am Soc Nephrol; 2002 Mar; 13(3):708-714. PubMed ID: 11856775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological use of L-carnitine in uremic anemia: has its full potential been exploited?
    Bonomini M; Zammit V; Pusey CD; De Vecchi A; Arduini A
    Pharmacol Res; 2011 Mar; 63(3):157-64. PubMed ID: 21138768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic adjuvants to erythropoietin therapy.
    Macdougall I
    Miner Electrolyte Metab; 1999; 25(4-6):357-64. PubMed ID: 10681667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. L-carnitine for anemia in hemodialysis patients: a last resort.
    Yee J
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1746-8. PubMed ID: 23085730
    [No Abstract]   [Full Text] [Related]  

  • 48. L-carnitine use in hemodialyzed patients.
    Mantovani LG; Belisari A
    Am J Kidney Dis; 1999 Aug; 34(2):400-1. PubMed ID: 10465727
    [No Abstract]   [Full Text] [Related]  

  • 49. Safety of oral carnitine in dialysis patients.
    Schreiber B
    Semin Dial; 2002; 15(1):71-2. PubMed ID: 11874598
    [No Abstract]   [Full Text] [Related]  

  • 50. Carnitine: an overview.
    Bazilinski N; Dunea G
    Int J Artif Organs; 1990 Nov; 13(11):720-2. PubMed ID: 2089009
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term effects of oral L-carnitine supplementation on anemia in chronic hemodialysis.
    Kudoh Y; Aoyama S; Torii T; Chen Q; Nagahara D; Sakata H; Nozawa A
    Cardiorenal Med; 2014 Apr; 4(1):53-9. PubMed ID: 24847334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term L-carnitine administration reduces erythropoietin resistance in chronic hemodialysis patients with thalassemia minor.
    Di Iorio BR; Guastaferro P; Cillo N; Cucciniello E; Bellizzi V
    Drug Target Insights; 2007; 2():1-7. PubMed ID: 21901057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of carnitine in disease.
    Flanagan JL; Simmons PA; Vehige J; Willcox MD; Garrett Q
    Nutr Metab (Lond); 2010 Apr; 7():30. PubMed ID: 20398344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients.
    Schreiber BD
    Blood Purif; 2006; 24(1):128-39. PubMed ID: 16361853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. L-carnitine supplementation in dialysis patients: does the evidence justify its use?
    Steinman TI
    Semin Dial; 2005; 18(1):1-2. PubMed ID: 15663752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.
    Arduini A; Bonomini M; Clutterbuck EJ; Laffan MA; Pusey CD
    Nephrol Dial Transplant; 2006 Sep; 21(9):2671-2. PubMed ID: 16611680
    [No Abstract]   [Full Text] [Related]  

  • 57. L-carnitine supplementation in dialysis: treatment in quest of disease.
    Wasserstein AG
    Semin Dial; 2013; 26(1):11-5. PubMed ID: 23173999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
    Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
    Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Debate forum: carnitine supplements have not been demonstrated as effective in patients on long-term dialysis therapy.
    Handelman GJ
    Blood Purif; 2006; 24(1):140-2. PubMed ID: 16361854
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.